KORI SCHULTE: Open Payments
NPI 1457452567 · MONUMENT, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$846 in 42 payments from 8 companies in 2025. Trend: 2023 $800 · 2024 $742 · 2025 $846
Food & beverage: $846
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 19 | $514 |
| GlaxoSmithKline, LLC. | 14 | $136 |
| GENZYME CORPORATION | 3 | $62 |
| Amgen Inc. | 2 | $44 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $30 |
| Lilly USA, LLC | 1 | $24 |
| Regeneron Healthcare Solutions, Inc. | 1 | $22 |
| Galderma Laboratories, L.P. | 1 | $14 |
Products named: TEZSPIRE, FASENRA, NUCALA, DUPIXENT, BREZTRI, TRELEGY ELLIPTA, EOHILIA, EBGLYSS.
Industry payments across CO — which companies pay providers there.
